Better treatments
start with Research

Pediatric Skin Research connect childrens with difficult skin conditions
to innovative clinical trials and emerging therapies

Check if your child qualifies
IRB approved
No Cost to Participate

How does it work?

1

Answer a few quick questions

2

We review your child’s eligibility

3

Speak with our research team

We’re researching better treatments for children with skin conditions

Alopecia Areata

Alopecia areata is an autoimmune condition that causes sudden hair loss, often appearing as round bald patches on the scalp. For many children, this condition can affect self-confidence and emotional well-being.

Check Eligibility now →

Atopic Dermatitis

This clinical research study is focused on children with moderate to severe atopic dermatitis (eczema), a common skin condition that can cause dry, itchy, and inflamed skin and may affect sleep, daily activities, and overall comfort.

Check Eligibility now →

Vitiligo

A child vitiligo study is now enrolling children ages 2–11 with non-segmental vitiligo — the kind that causes white patches on the face or body. No cure is promised. But families who participate help shape what’s possible next.

Check Eligibility now →

News & Events

Explore the Pedskin Blog

Explore the Blog
Mother and son smiling together holding a 'Best Mom' drawing of a trophy.
TESTIMONIALS

“Finding the study for my child was fantastic, but finding a group of other mothers who genuinely understood them was what truly saved me”.

Nancy Garcia, Sunrise FL

We are here to provide clarity.

Get straightforward explanations about how the research works, what it does, and how it supports your child’s health journey.

Safety is the study’s top priority. The investigational medication has been studied in adults and is now being evaluated in adolescents. Your teen will be closely monitored with regular bloodwork, vital signs, and clinical assessments. An independent safety committee also reviews data continuously throughout the study.

There is no cost to participate. Study medication, clinic visits, and all study-related lab work are provided at no charge. Participants may also receive compensation for time and travel — please speak with our team for details.

Families are free to withdraw from the study at any time without consequence. Participation is entirely voluntary.

The full study lasts approximately 80 weeks: up to 28 days of screening, 24 weeks of double-blind treatment, 52 weeks of open-label extension where all participants receive the active medication, and a 4-week follow-up. Medication is taken orally twice daily.

After completing the open-label extension, participants finish a 4-week follow-up visit. Our team will discuss ongoing care options at that time. Data collected will help advance treatment options for adolescents with alopecia areata.

/

We are here to provide clarity.

Safety is the study’s top priority. The investigational medication has been studied in adults and is now being evaluated in adolescents. Your teen will be closely monitored with regular bloodwork, vital signs, and clinical assessments. An independent safety committee also reviews data continuously throughout the study.

Families are free to withdraw from the study at any time without consequence. Participation is entirely voluntary.

There is no cost to participate. Study medication, clinic visits, and all study-related lab work are provided at no charge. Participants may also receive compensation for time and travel — please speak with our team for details.

After completing the open-label extension, participants finish a 4-week follow-up visit. Our team will discuss ongoing care options at that time. Data collected will help advance treatment options for adolescents with alopecia areata.

Why participate in a research study?

Clinical research plays a crucial role in providing children with access to new treatments and advancing medical knowledge for future generations. Our mission is to create new opportunities for children and families by advancing research and ensuring that they have access to innovative therapies that have the potential to transform lives.

Dr. Mercedes E. González

Pediatric Dermatology Specialist & Principal Investigator

Your teen may qualify for this study.

If your child has severe alopecia areata and is between the ages of 12 and 17, find out in less than 2 minutes whether they may be eligible to participate at no cost to your family.

Check Eligibility Now →

It only takes 20 seconds.

8950 N. Kendall Drive, Suite 504, Miami, FL 33176 Phone: (305) 555-0100. About Us · Contact Us · Privacy Policy · Terms of Service

© 2026 Pediatric Skin Research Inc. All rights reserved.